US Material Events SEC 8-K Filings — July 14, 2026

14-07-2026

NextCure, Inc. (NXTC) and Avere Therapeutics announced a definitive all-stock merger agreement to advance Avere's once-weekly oral IL-23 therapy AVR-001. Concurrently, a $320 million private placement led by Fairmount and Hansoh Pharmaceutical Group will fund the combined company through Phase 2b readout in psoriasis and initiation of Phase 3 and Phase 2b trials. Pre-merger NextCure stockholders will own only ~1.21% of the combined company, while Avere stockholders will own ~98.79%, reflecting a massive dilution for existing NextCure shareholders.

• · NextCure stockholders will receive a contingent value right (CVR) entitling them to 90% of net proceeds from any future monetization of NextCure's pipeline assets for two years post-closing.
• · The combined company will operate as Avere Therapeutics, Inc. and trade on Nasdaq under ticker 'AVRX'.
• · Avere's licensing agreement with Hansoh includes up to $2.18B in development and sales milestones plus mid-single to low-double digit royalties.
• · AVR-001 has a half-life of ~100 hours enabling once-weekly oral dosing; Phase 1b data showed Week 4 and Week 8 PASI and PASI 75 responses comparable to a once-daily oral inhibitor.
• · US IND for AVR-001 is open; Phase 2b study initiation by Avere expected in early 2027 with readout in H1 2028.
• · Hansoh's Phase 2b psoriasis study in China expected to read out in 2027.
• · Transaction expected to close in H2 2026, subject to stockholder approvals and SEC registration statement effectiveness.

14-07-2026

Kestra Medical Technologies reported strong fiscal Q4 2026 revenue of $28.6M, up 66% YoY, and FY26 revenue of $95.1M, up 59% YoY, driven by higher market share and WCD market expansion. Gross margin improved significantly to 54.8% in Q4 (vs 44.3%) and 51.4% for FY26 (vs 40.5%). However, GAAP net loss widened to $131.6M for FY26 from $113.8M in FY25, and adjusted EBITDA loss increased to $87.0M from $68.4M, reflecting heavy investment in commercial expansion. The company guided FY27 revenue of $137M, representing 44% growth.

• · FY26 GAAP operating expenses increased to $183.6M from $130.6M in FY25, a 40.6% increase.
• · Adjusted operating expenses for FY26 were $144.6M vs $100.6M in FY25, up 43.7%.
• · Net cash used in operating activities improved to $18.7M in Q4 FY26 from $24.1M in Q4 FY25.
• · Cash and investments totaled $262.2M as of April 30, 2026, down from $237.6M in cash alone a year earlier (due to investment in short-term and long-term securities).
• · The company had 58,383,924 common shares outstanding as of April 30, 2026, up from 51,348,656 a year earlier.
• · Accumulated deficit grew to $651.9M from $520.2M.

14-07-2026

Two Hands Corp filed an 8-K on July 14, 2026, reporting multiple material events including entry into a definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and an unregistered sale of equity securities (Item 3.02). The filing is multi-item and mandatory, but no specific dollar values, share counts, or transaction details are disclosed in the summary. The filing appears to be timely but lacks quantitative data, limiting assessment of materiality and market impact.

• · Filing date: July 14, 2026
• · Filing size: 5 MB
• · AccNo: 0001494413-26-000032
• · Sector: not specified
• · No financial statements or exhibits details provided in summary

14-07-2026

Research Alliance Corporation IV, a SPAC sponsored by an affiliate of RA Capital Management, priced its $75 million initial public offering of 7.5 million Class A ordinary shares at $10.00 per share. The shares will trade on the Nasdaq Capital Market under the ticker 'RACD' starting July 13, 2026, with the offering expected to close on July 14, 2026. The company intends to focus its search for a business combination target in the healthcare or healthcare-related industries.

• · The registration statement was declared effective by the SEC on July 10, 2026.
• · The offering is being made only by means of a prospectus; copies can be obtained from Leerink Partners.
• · The company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
• · The company may pursue an initial business combination in any business, industry, sector or geographical location, but intends to focus on healthcare or healthcare-related industries.
• · The financing included participation from 17 institutional investors listed in the press release.

14-07-2026

Alto Neuroscience, Inc. entered into an underwriting agreement on July 13, 2026, to issue and sell 3,776,436 shares of common stock at $26.48 per share in a registered direct offering, expecting net proceeds of approximately $93.9 million. The company intends to use the proceeds to accelerate clinical development of ALTO-207, including an additional planned Phase 3 trial for treatment-resistant depression, and for working capital. The offering is expected to close on July 14, 2026.

• · The offering is conducted under an effective shelf registration statement on Form S-3 (File No. 333-284667).
• · Underwriters have agreed to reimburse the company for certain expenses in connection with the offering.
• · The underwriting agreement contains customary representations, warranties, covenants, indemnification obligations, and termination provisions.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.

14-07-2026

Planet Green Holdings Corp. (PLAG) entered into an ATM Sales Agreement with Curvature Securities, LLC on July 13, 2026, allowing the company to sell up to approximately $8.9 million of its common stock in at-the-market offerings. The company's public float is approximately $26.8 million based on 11.6 million shares held by non-affiliates at a $2.30 closing price. The agreement provides flexibility but does not obligate the company to sell any shares, and no assurance can be given that any sales will occur.

• · The Sales Agreement was entered into on July 13, 2026, and the prospectus supplement is dated the same day.
• · The company's effective shelf registration statement on Form S-3 (File No. 333-294386) was initially filed on March 17, 2026, and declared effective on April 13, 2026.
• · The Agent's commission is 3.0% of gross proceeds, and the company also reimburses the Agent for certain specified expenses.
• · During the 12 calendar months prior to and including the date of this report, the company has not sold any securities in reliance on General Instruction I.B.6 of Form S-3.
• · The company's public float is below $75 million, triggering the one-third public float limitation under General Instruction I.B.6.

14-07-2026

Coronado Global Resources Inc. announced the appointment of Barrie van der Merwe, currently CFO, as CEO and Managing Director effective August 1, 2026, succeeding interim CEO Gerry Spindler who will remain as a non-executive director. The company also appointed Sandeep Deoji as interim CFO. The Board stated the need to return the business to profitability and reduce debt, indicating current financial challenges.

• · Barrie van der Merwe has over three decades of mining industry experience and has been CFO since 2025.
• · The Board conducted a thorough recruitment process before appointing van der Merwe.
• · Gerry Spindler, interim CEO and founder, will remain on the Board as a non-executive director.
• · Sandeep Deoji will serve as interim CFO effective August 1, 2026, until a permanent appointment is made.
• · The new CEO's employment includes a 12-month restraint provision and a termination payment of six months' base salary if terminated other than for cause.
• · The company's Chairman stated the business needs to be returned to profitability and reduce debt to open up new strategic options.

14-07-2026

Goosehead Insurance entered into an Amended and Restated Stockholders Agreement on July 8, 2026, implementing a court-approved settlement of the Dollens stockholder litigation. The agreement grants Pre-IPO Holders approval rights over major corporate actions and board nominations as long as they hold at least 10% of outstanding common stock. No financial metrics or comparative performance data are reported in this filing.

• · The Pre-IPO Holders may designate nominees for a majority of the board, including the Chairman, until they hold less than 10% of outstanding common stock.
• · The A&R Stockholders Agreement requires Pre-IPO Holder approval for CEO, CFO, COO, General Counsel, and Controller compensation decisions.
• · The original settlement was proposed in August 2023, and the court issued final approval on June 30, 2026.
• · A reversal of the Moelis decision by the Delaware Supreme Court in January 2026 did not alter the company's obligation to finalize the settlement.

14-07-2026

Datavault AI Inc. engaged CBIZ CPAs P.C. as its new independent registered public accounting firm for the quarter ended June 30, 2026, the quarter ending September 30, 2026, and the fiscal year ending December 31, 2026. The company stated that there were no prior consultations with CBIZ on accounting principles or any disagreements or reportable events during the two most recent fiscal years. The change was announced via a press release on July 13, 2026.

• · The engagement date was July 10, 2026.
• · The prior fiscal years covered for no-consultation review were ended December 31, 2025 and December 31, 2024.
• · The company's common stock trades on Nasdaq under symbol DVLT.
• · The press release was issued on July 13, 2026 and is attached as Exhibit 99.1.

14-07-2026

Spero Therapeutics and Innovent Biologics announced an exclusive license agreement for SP001 (IBI355), a Phase 2-ready third-generation anti-CD40L antibody. Under the terms, Spero receives exclusive global rights excluding Greater China, while Innovent receives an upfront payment and is eligible for development, regulatory, and commercial milestone payments totaling approximately US$1.1 billion, plus tiered royalties on net sales. Spero plans to initiate a Phase 2 trial in IgG4-related disease in Q2 2027, and Innovent plans a Phase 2 trial in Sjögren's disease in China by early 2027.

• · SP001 is a third-generation, humanized, Fc-silent IgG1 monoclonal antibody targeting CD40L, designed to address platelet activation concerns associated with earlier anti-CD40L antibodies.
• · Phase 1b data in Sjögren's disease was presented at the EULAR 2026 Congress.

14-07-2026

Bread Financial Holdings, Inc. announced the retirement of EVP and Chief Commercial Officer Valerie Greer after nearly four decades in financial services, effective February 2027. Dennis McCarthy will be promoted to EVP and Chief Revenue Officer in early September 2026, reporting to the CEO. The changes reflect a planned leadership transition in the commercial organization.

• · Greer joined Bread Financial in 2020 and led expansion of product suite, marketing, digital, and customer experience organizations.
• · McCarthy joined the company in 2021 and played a central role in advancing the client partnership team's operating model and driving renewal success of key partner relationships.
• · McCarthy previously held leadership roles at Citi, Barclays, and Bank of America.

14-07-2026

Fidelity Private Credit Company LLC entered into a Consent and Fifth Amendment to its Loan and Security Agreement dated July 9, 2026, to facilitate a merger with Fidelity Private Credit Company II LLC (New Parent) and a subsequent name change back to 'Fidelity Private Credit Company LLC'. The amendment, consented to by lenders including JPMorgan Chase, allows New Parent to assume all rights and obligations as Parent, Portfolio Manager, and Seller under the credit facility. No financial terms or changes to borrowing capacity were disclosed.

• · The Merger Agreement was entered into on March 25, 2026.
• · The original Loan and Security Agreement was dated August 25, 2022.
• · The Fifth Amendment Effective Date is July 9, 2026.
• · The amendment includes a conformed copy of the Credit Agreement through the Fifth Amendment.
• · The amendment adds a new Exhibit C to the Credit Agreement.

14-07-2026

Federal Home Loan Bank of Boston disclosed that EVP, COO and CFO Frank Nitkiewicz notified the Bank of his intent to retire by March 31, 2027. His departure is not due to any disagreement with auditors or management on accounting matters. The Bank will conduct a search for a new CFO and plans to redistribute the COO duties among other officers.

• · Mr. Nitkiewicz's retirement is not the result of any disagreement with the Bank's independent auditors or any member of management on any matter of accounting principles or practices, financial statement disclosure, or internal controls.
• · Until his retirement, Mr. Nitkiewicz will continue to serve as the Bank's principal financial officer and principal operating officer.
• · Upon Mr. Nitkiewicz's retirement, the Bank intends to apportion the principal operating officer's duties among other officers and employees.

14-07-2026

Willamette Valley Vineyards appointed Christopher Riccardi and Greg Voorhies as directors on July 11, 2026, effective immediately. Both join director group III with terms expiring at the 2028 annual meeting. No material transactions or arrangements were disclosed.

• · Directors appointed to group III with term expiring at 2028 annual meeting.
• · Compensation follows the WVV Board Member Compensation Plan as described in the proxy statement filed May 28, 2026.
• · No arrangements or understandings with any person regarding the appointments.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K.

14-07-2026

Redwire Corp appointed Gregory L. Heston, a retired EY audit partner with 38 years of experience, to its Board of Directors effective July 10, 2026, filling the vacancy left by David Kornblatt's resignation. Heston will serve as a Class III director until the 2027 Annual Meeting and joins the Audit Committee. The filing does not disclose any financial performance data or new business initiatives.

• · Heston is a licensed CPA in Alabama and Georgia.
• · He was appointed to the Audit Committee of the Board.
• · The Board determined Heston is independent under NYSE and Rule 10A-3 standards.
• · Heston currently serves on the Board of Geneva Benefits Group and is a Professor of Practice at Auburn University.

14-07-2026

Repay Holdings Corp appointed Zachary F. Sadek to its Board of Directors effective July 13, 2026, expanding the board to seven directors, six of whom are independent. Mr. Sadek is a Senior Partner at Parthenon Capital Partners, an affiliate of one of the company's largest stockholders, and his appointment follows a cooperation agreement between the company and Parthenon Capital. The filing highlights constructive engagement and a shared commitment to driving improved performance and long-term value, but provides no specific financial metrics or performance data.

• · The appointment is in connection with a cooperation agreement between the company and Parthenon Capital, which will be filed separately as an exhibit to an 8-K.
• · Mr. Sadek brings over two decades of experience in payments, financial technology, business services, and software sectors.
• · The filing references the successful integration of KUBRA in forward-looking statements, but no financial details are provided.

14-07-2026

Edgemode, Inc. entered into a Securities Purchase Agreement with Vanquish Funding Group Inc. on July 8, 2026, issuing an unsecured promissory note with a principal amount of $129,600 for net proceeds of $100,000, reflecting a 22.4% original issue discount. The note carries a 15% interest charge (22% upon default), is convertible into common stock at a 61% discount to the lowest trading price over the prior 20 days upon an event of default, and requires four monthly payments starting January 15, 2027. The proceeds are earmarked for working capital, but the highly dilutive conversion terms and the fact that the company paid $8,000 in fees to the investor and its counsel indicate a costly financing structure.

• · The note matures on April 15, 2027.
• · Conversion is only permitted following an event of default.
• · The company is not an emerging growth company.
• · The securities were issued in a private placement under Section 4(a)(2) of the Securities Act.
• · The company's common stock is not listed on any national exchange (no trading symbol or exchange name provided).

14-07-2026

Nerdy Inc. appointed Kyle Callaway as Chief Accounting Officer effective July 10, 2026. Mr. Callaway, previously the Company's Controller since January 2021 and Vice President since 2022, will report to CFO Atul Bagga. The filing contains no financial results or period-over-period comparisons.

• · Kyle Callaway has served as Controller since January 2021 and was promoted to Vice President in 2022.
• · He previously served as Senior Director of Technical Accounting and Reporting at Post Holdings, Inc. from November 2017 to January 2021.
• · He spent ten years at PricewaterhouseCoopers LLP, most recently as an Assurance Senior Manager.
• · He holds a Master of Accountancy and a Bachelor of Science in Accountancy from the University of Missouri-Columbia and is a CPA licensed in Missouri.
• · No family relationships or related party transactions exist between Mr. Callaway and the Company.

14-07-2026

Fortrea Holdings Inc. disclosed the resignation of Chief Accounting Officer Robert A. Parks, effective August 7, 2026, to pursue an opportunity outside the CRO industry, with no disagreement with the company. Carrie Russell, VP of Accounting, will assume the role of interim principal accounting officer and interim CAO, receiving a one-time $20,000 bonus and $10,000 per month additional cash bonus. Separately, the company finalized a transition agreement with departing CFO Jill McConnell, who will remain through September 8, 2026, and then serve as a consultant through March 8, 2027, with severance of $1,017,500 and continued equity vesting.

• · Robert A. Parks' resignation is effective August 7, 2026, and he will assist with transition until then.
• · Carrie Russell has been VP of Accounting since August 2024 and previously spent nearly 17 years at PwC, including two years in the National Office SEC Services group.
• · Carrie Russell is a CPA and holds a B.S. in Business Administration and a Master of Accountancy from UNC Chapel Hill.
• · Jill McConnell's transition period ends September 8, 2026, followed by a consulting period through March 8, 2027.
• · During the consulting period, Jill McConnell's outstanding restricted stock units will continue to vest.
• · The Transition Agreement and Consulting Agreement will be filed with the Q3 2026 10-Q.

14-07-2026

Wabash National reported preliminary Q2 2026 results showing a significant deterioration in performance, with net sales estimated between $413M and $421M, an 8-10% decline from $458.8M in Q2 2025. The company swung to a net loss of $23.3M-$26.2M compared to a $9.6M loss in the prior year, and adjusted EBITDA turned negative at -$9.7M to -$12.6M versus positive $16.3M. However, backlog remained strong at over $950M, and the company is pursuing a $275M amendment to its revolving credit facility to improve liquidity.

• · Backlog exceeded $950M as of June 30, 2026, indicating strong future demand despite current weakness.
• · The company is pursuing a $275M amendment to its $350M revolving credit facility, with potential upsizing, to extend maturity and add a $90M minimum liquidity requirement.
• · Wabash has $400M in 4.50% Senior Notes due 2028 and is actively considering refinancing options.
• · Facility idling and related costs of $1.8M were incurred in Q2 2026, contributing to the adjusted EBITDA decline.
• · The Missouri legal matter, which added $4.6M in costs in Q2 2025, was resolved with no charges in Q2 2026.

14-07-2026

Velo3D, Inc. entered into registration rights agreements on July 13, 2026, with Arrayed Notes Acquisition Corp. and Thieneman Construction, Inc. following the conversion of $5 million and $10 million senior secured convertible promissory notes, respectively, into common stock on March 4, 2026. The agreements grant the holders up to two demand registrations and customary piggyback rights, with Arrayed being an affiliate of the CEO and Chairman Arun Jeldi. No financial performance metrics are disclosed in this filing.

• · The conversion of the notes occurred on March 4, 2026.
• · Arrayed is an affiliate of Arun Jeldi, the Company's CEO and Chairman.
• · Each Registration Rights Agreement provides up to two demand registrations with minimum offering prices of $2.5M (Arrayed) and $5M (Thieneman).

14-07-2026

Propanc Biopharma, Inc. announced the retirement of director Annie Van Broekhoven effective July 8, 2026, and the appointment of Carlo Campiciano to fill the vacancy. Mr. Campiciano brings extensive financial and governance experience, including serving as CFO and Company Secretary of MedAdvisor Limited and holding a US GAAP certification. The filing contains no financial results or period-over-period comparisons.

• · Annie Van Broekhoven retired and resigned from the Board effective July 8, 2026.
• · Carlo Campiciano was appointed to the Board on the same day.
• · Mr. Campiciano is a qualified accountant, member of the Institute of Public Accountants in Australia, and holds US GAAP certification.
• · He has been CFO and Company Secretary of MedAdvisor Limited (ASX-listed) since its launch in 2012 and was instrumental in its capital raising and ASX listing in December 2015.
• · He also lectured in venture finance for twelve years at Swinburne Graduate School of Entrepreneurship.

14-07-2026

Oncotelic Therapeutics granted 17,796 RSUs to directors, officers, employees, and advisors on July 10, 2026. Each RSU converts into one share of Series A Convertible Preferred Stock, which is convertible into 1,000 shares of common stock. Vesting is contingent on the company's common stock being uplisted to a national exchange by June 30, 2027, and the recipient remaining in service for six months post-uplisting; otherwise, RSUs are forfeited.

• · Each RSU represents the contingent right to receive one share of Series A Convertible Preferred Stock, which is convertible into 1,000 shares of common stock.
• · Vesting requires uplisting to a national exchange by June 30, 2027, and continued service for six months after uplisting.
• · If uplisting does not occur by June 30, 2027 (or as extended by the Board), or if service terminates before six months post-uplisting, RSUs are forfeited.
• · The RSUs were issued in reliance on Section 4(a)(2) of the Securities Act, exempt from registration.

14-07-2026

Domino's Pizza announced the appointment of Michael C. Creedon, Jr. (CEO of Dollar Tree) and Anneliese Olson (President at HP Inc.) as new independent directors, and elected Corie Barry (CEO of Best Buy) as Lead Independent Director. The changes strengthen the board with consumer and technology expertise, while Richard Federico remains on the board and as Audit Committee Chairman. No financial metrics or performance data were disclosed in this filing.

• · Corie Barry has served on Domino's Board since July 2018 and is Chairperson of the Compensation and Human Capital Committee.
• · Michael Creedon will serve on the Audit Committee.
• · Anneliese Olson will serve on the Audit Committee.
• · Richard Federico continues as board member and Chairman of the Audit Committee.
• · Domino's was founded in 1960 and is the largest pizza company in the world.

14-07-2026

Jaguar Health, Inc. subsidiary Napo Pharmaceuticals entered into a new manufacturing and supply agreement with Alivus Life Sciences Limited on July 9, 2026, replacing the prior agreement that expired on March 31, 2026. The 2026 Agreement secures continued supply of crofelemer for Mytesi® and other crofelemer-based products through March 31, 2029, with minimum purchase commitments and provisions for termination, including for insolvency events that would trigger assignment to Woodward Specialty LLC. The agreement ensures continuity of supply for the company's FDA-approved drug but includes financial obligations for minimum quantities and potential shortfall payments.

• · The 2020 Agreement was originally entered on September 3, 2020, renewed on July 12, 2023, and expired on March 31, 2026.
• · The 2026 Agreement includes minimum purchase quantities of crofelemer, with potential shortfall payment obligations for Napo.
• · Either party may terminate the 2026 Agreement for any reason with 12 months' prior written notice.
• · Material breach termination requires a 90-day cure period.
• · Immediate termination rights exist for bankruptcy, insolvency, dissolution, or assignment for benefit of creditors.
• · Napo may terminate immediately if regulatory authorities withdraw crofelemer or any crofelemer-based product for safety/non-compliance reasons.
• · Napo may terminate upon 30 days' notice for chronic failure to supply crofelemer.
• · Rights under the 2026 Agreement would be assigned to Woodward Specialty LLC if an Insolvency Event occurs under the License Agreement dated January 12, 2026.

14-07-2026

PagerDuty appointed Alex Shootman, CEO of Alkami Technology, to its Board of Directors effective July 14, 2026, replacing Elena Gomez who resigned to focus on her CFO role at Toast. Shootman brings over 25 years of enterprise SaaS scaling experience, including leading Workfront through its $1.5B acquisition by Adobe and guiding Eloqua through its IPO and $900M sale to Oracle. The appointment strengthens PagerDuty's governance as it pushes deeper into the enterprise market with its AI-first operations platform.

• · PagerDuty is trusted by approximately two-thirds of the Fortune 100 and nearly half of the Fortune 500.
• · The PagerDuty Operations Cloud integrates with over 750 integrations.
• · Elena Gomez served on the PagerDuty board for nearly eight years.

14-07-2026

Cheniere Energy Partners, L.P. appointed Michael Jennings and Zamir Rauf to its Board of Directors effective July 14, 2026, replacing James R. Ball and Oliver G. Richard, III who resigned. Both new directors are independent and received annual equity awards of $200,000 in phantom units and an annual cash fee of $100,000. The resignations were not due to any disagreement with the Partnership.

• · Mr. Jennings served as CEO of HF Sinclair Corporation from January 2020 to May 2023 and most recently on the board of Parkland Corporation from February 2024 until its acquisition by Sunoco LP in October 2025.
• · Mr. Rauf served as Executive Vice President and CFO of Calpine Corporation from December 2008 until its acquisition by Constellation Energy in January 2026.
• · Mr. Jennings was appointed to the Conflicts Committee and the CMI SPA Committee; Mr. Rauf was appointed to the Conflicts Committee, Audit Committee, and Executive Committee.
• · The appointments were made pursuant to the rights of Cheniere GP Holding Company, LLC under the Amended LLC Agreement.
• · Vesting of phantom units occurs on the first anniversary of the grant date, payable in common units, cash, or a combination at the director's election.

14-07-2026

West Pharmaceutical Services, Inc. has entered into an Amended and Restated Technology Exchange and Crosslicense Agreement and two Distributorship Agreements with Daikyo Seiko, Ltd., effective July 14, 2026. The agreements, which have a 10-year term, are substantially similar to prior agreements from 2017 and cover joint development and distribution of pharmaceutical packaging and delivery products. West holds a 49% ownership interest in Daikyo.

• · The Crosslicense Agreement is royalty-free except for a fixed royalty rate applicable to certain patents and non-patented technical information.
• · West's license from Daikyo is exclusive outside of Japan subject to certain limited exceptions; Daikyo's license from West is non-exclusive.
• · One Distributorship Agreement authorizes West as exclusive distributor of Daikyo products outside Japan; the other authorizes Daikyo as non-exclusive distributor of West products in Japan.
• · Each agreement may be terminated before its 10-year term under certain circumstances, including mutual written consent or change in control of either party.
• · If the Crosslicense Agreement is terminated, the parties have agreed to negotiate terms for continued use of know-how and trademarks.

14-07-2026

PVH Corp. appointed Alexis Rollier as Chief Financial Officer, effective early September 2026. Rollier brings over 30 years of global finance and omni-channel retail experience, most recently as Global COO and CFO at LVMH-owned Sephora. He will succeed interim CFO Melissa Stone, who will continue leading Global FP&A and support the transition.

• · Rollier will join PVH in early September 2026 and report to CEO Stefan Larsson.
• · Melissa Stone served as Interim CFO since January 1, 2026, and will continue to lead Global FP&A.
• · Rollier has lived and worked in both the U.S. and Europe, leading teams across North America, Europe, the Middle East, and Latin America.
• · He started his career at Arthur Andersen and earned his MBA at ESSEC Business School.

14-07-2026

Allstate Corporation announced the appointment of Christian (Chris) Lown as Executive Vice President and Chief Financial Officer, effective August 3, 2026. Lown brings over 25 years of senior leadership experience from CoStar Group, Freddie Mac, Navient Corporation, Morgan Stanley, and UBS. He will succeed Jess Merten, who was named President of Property-Liability in October 2025, and John Dugenske will continue as interim CFO until Lown joins.

• · Lown's appointment is effective August 3, 2026.
• · Lown earned an MBA from the University of Virginia Darden School of Business and a bachelor's degree in international relations from the University of Lynchburg.
• · Allstate has more than 212 million policies in force.

14-07-2026

AutoZone completed the sale of $850,000,000 aggregate principal amount of 4.950% Senior Notes due 2031 on July 14, 2026. The notes bear interest at 4.950% per year payable semi-annually, mature on July 15, 2031, and are senior unsecured obligations ranking equally with the company's other senior unsecured liabilities. The offering was made under a shelf registration statement filed on July 7, 2026.

• · Interest on the Notes is payable semi-annually on January 15 and July 15, beginning January 15, 2027.
• · The Notes are subject to customary covenants restricting liens, sale and leaseback transactions, mergers, and asset sales.
• · Holders of 25% in aggregate principal amount of outstanding Notes may declare them immediately due upon an event of default after any grace period.
• · The Company may redeem the Notes at its option with 10 to 60 days' notice at specified redemption prices.
• · Holders may require repurchase upon a change of control triggering event, unless the Company has already exercised its redemption option.

14-07-2026

Cheniere Energy appointed Britt Vitalone, former EVP and CFO of McKesson Corporation, as an independent director effective July 14, 2026. He will serve on the Audit and Compensation Committees. The appointment adds over 30 years of executive leadership and financial expertise to the board, with no negative or flat metrics to report.

• · Britt Vitalone holds a B.S. in Accounting from St. John Fisher University and is a CPA (New York) and member of the AICPA.
• · He also serves on the board and audit committee of Align Technology, Inc.
• · Cheniere has additional offices in London, Singapore, Beijing, Tokyo, Dubai, and Washington, D.C.

14-07-2026

Evofem Biosciences, Inc. (EVFM) entered into a promissory note agreement with Hub Cyber Security Ltd. for a principal amount of $706,304.00, effective July 8, 2026. The note carries a 12% annual interest rate, compounded monthly, and matures in 11 months. Proceeds are restricted to payments to suppliers for the company's products, Phexx and Solosec, and the note is subordinated to senior indebtedness, including obligations to Future Pak, LLC.

• · The note is subordinated to senior indebtedness under a Securities Purchase and Security Agreement dated April 23, 2020, and a Securities Purchase Agreement dated October 14, 2020.
• · Maker (Evofem) is restricted from merging, selling assets, dissolving, or amending organizational documents without prior written consent of the holder.
• · An Event of Default includes failure to pay principal or interest when due, bankruptcy filings, and failure to perform covenants.
• · The note is unregistered and subject to restrictions on transfer under the Securities Act of 1933.

14-07-2026

SunPower Inc. announced the departure of Jeanne Nguyen, its former Chief Accounting Officer, effective July 8, 2026. The filing does not disclose a successor or any financial impact from the departure.

• · The departure was effective July 8, 2026, and the filing was made on July 14, 2026.
• · No reason for the departure or any related compensatory arrangements were disclosed.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.

14-07-2026

Equinix announced that Chief Business Officer Jon Lin will separate from the company effective July 18, 2026, with severance under the Executive Severance Plan. Responsibilities are being redistributed among existing senior leadership, and a new Chief Product Officer is expected to be announced soon. No financial figures or period-over-period comparisons are provided in this filing.

• · Jon Lin's departure is effective July 18, 2026.
• · Severance is subject to a release of claims and governed by the Executive Severance Plan described in the February 12, 2026 8-K.
• · A new Chief Product Officer is expected to be announced in the near future.

14-07-2026

AMREP Corp. awarded cash bonuses and restricted stock to its CEO and CFO on July 13, 2026, and approved salary increases effective July 27, 2026. CEO Christopher V. Vitale received a $178,000 cash bonus and 8,700 restricted shares, with a new salary of $395,000. CFO Adrienne M. Uleau received a $64,000 cash bonus and 2,250 restricted shares, with a new salary of $205,000. No negative or flat metrics are present in this filing.

• · CEO's restricted shares vest in three equal tranches of 2,900 shares on July 13, 2027, 2028, and 2029.
• · CFO's restricted shares vest in three equal tranches of 750 shares on July 13, 2027, 2028, and 2029.
• · Salary changes are effective as of July 27, 2026.

14-07-2026

Starfighters Space, Inc. disclosed on July 14, 2026 that its independent auditor, Adeptus Partners, LLC, resigned effective July 9, 2026. The company is in the process of selecting a successor. While there were no disagreements or reportable events with Adeptus, the auditor's reports for fiscal years 2024 and 2025 included an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern.

• · The auditor's resignation was effective immediately on July 9, 2026.
• · Adeptus' reports for fiscal years ended December 31, 2025 and 2024 contained an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern.
• · No disagreements or reportable events occurred during the fiscal years 2024 and 2025 or the subsequent interim period through July 9, 2026.

14-07-2026

Ulta Beauty announced the appointment of Kelly Garcia as Chief Technology Officer, effective August 31, 2026. Mr. Garcia, who has served on the Ulta Beauty Board of Directors since 2022, will resign from the Board upon his start date. He brings over 25 years of leadership experience in global e-commerce, digital innovation, and cybersecurity, most recently as EVP and CTO of Domino's Pizza since 2012.

• · Mr. Garcia holds a B.S. in computer science and engineering from The Ohio State University.
• · Ulta Beauty operates more than 1,500 stores across the U.S. and is expanding internationally through Space NK (U.K./Ireland), a joint venture in Mexico, and a franchise in the Middle East.

14-07-2026

Churchill Capital Corp XII appointed Paul Lapping as a director, audit committee chair, and compensation committee member effective July 13, 2026, replacing William Sherman as interim audit committee chair. The company also entered into director agreements with both Lapping and Sherman, providing each with $75,000 per annum cash compensation starting August 1, 2026. No financial results or business combination updates were disclosed.

• · Paul Lapping, age 63, is Manager of Jakal Investments, LLC (founded 2005) and Green Pastures Management, LLC (since April 2015).
• · Lapping serves as director of Churchill Capital Corp IX (since April 2025) and Churchill Capital Corp XI (since March 2026).
• · Lapping previously served as director of Churchill Capital Corp X (Aug 2025–Feb 2026), which completed its business combination with Infleqtion, Inc. in February 2026.
• · Lapping passed the Uniform CPA Examination in 1984 and holds a B.S. from University of Illinois and an M.B.A. from Northwestern University.
• · Lapping signed a joinder to the letter agreement dated April 27, 2026, waiving certain redemption rights and agreeing to vote shares in favor of an initial business combination.
• · Director agreements are effective August 1, 2026, and continue until the earlier of director's cessation or consummation of the initial business combination.
• · Directors waived any right to monies in the Company's trust account.

14-07-2026

Apollo-managed funds completed the acquisitions of Emerald Holding, Inc. and Questex, LLC, creating a scaled B2B experiential events and media platform. Emerald stockholders received $5.03 per share in cash, and the company's common stock has ceased trading on the NYSE. The combined company appointed a new executive leadership team, including Paul Miller as CEO and Vince DiMaggio as CFO, with full integration expected over the coming months.

• · The two companies will be fully integrated over the coming months.
• · Emerald's common stock has ceased trading and will no longer be listed on the New York Stock Exchange.
• · Advisors: Goldman Sachs & Co. LLC acted as exclusive financial advisor and Fried, Frank, Harris, Shriver & Jacobson LLP as legal counsel to Emerald; Gibson, Dunn & Crutcher LLP acted as legal counsel to Questex; RBC Capital Markets and RAN Advisory acted as lead financial advisors and PJT Partners as financial advisor to the Apollo Funds; Akin Gump Strauss Hauer & Feld LLP acted as legal counsel to the Apollo Funds.
• · Apollo had approximately $1.03 trillion of assets under management as of March 31, 2026.

14-07-2026

American Well Corporation (AMWL) filed an 8-K on July 14, 2026, disclosing the resignation and re-appointment of director Stephen Schlegel to rebalance the Board's classes. The move was made solely to comply with NYSE listing standards requiring approximately equal class sizes, and not due to any disagreement with the company. Mr. Schlegel's committee assignments and compensation remain unchanged.

• · Stephen Schlegel resigned as a Class II director on July 8, 2026, and was re-appointed as a Class III director on July 11, 2026.
• · The reclassification restores the three Board classes to approximately equal size, as required by NYSE listing standards.
• · The change was prompted by directors who did not stand for re-election, causing class size imbalance.
• · Mr. Schlegel's term as Class III director expires at the 2029 annual meeting of stockholders.
• · No changes were made to Mr. Schlegel's committee assignments or compensatory arrangements.

14-07-2026

Accel Entertainment announced the promotion of Stan Guidroz from CEO of its Toucan Gaming subsidiary to Chief Operating Officer, effective July 14, 2026. In connection, Mark Phelan will relinquish the COO title but continue as President and become CEO in August 2026. Separately, Chief Compliance Officer Derek Harmer will transition out of his role by March 31, 2027 and join the compliance committee. The changes reflect leadership succession and retention of key talent.

• · Stan Guidroz founded the Louisiana Video Gaming Association in 2015 and served as its President through 2025, helping advance legislation for the state's local gaming market.
• · Mark Phelan was previously announced as becoming CEO in August 2026; the COO title is being transferred to Guidroz, not vacated.
• · Derek Harmer will transition from Chief Compliance Officer effective March 31, 2027, and then serve on the gaming Compliance Committee starting April 1, 2027.
• · Guidroz oversaw the recent acquisition of Rice Palace Truck Stop Casino as part of his role at Toucan.
• · Accel's scale: over 28,000 electronic gaming terminals, 4,500 third-party locations, 20 self-operated sites across 10 states.

14-07-2026

Strategic Storage Trust VI, Inc. (SST VI) announced an all-stock merger to acquire Strategic Storage Growth Trust III, Inc. (SSGT III), creating a combined company with an expected total asset value of approximately $1.2 billion. The merger will add 12 wholly owned self-storage facilities, joint venture interests, and beneficial interests in three DST programs to SST VI's existing portfolio. Existing SST VI stockholders will own approximately 59% of the combined company, while SSGT III stockholders will own approximately 38%, with the remaining 3% held by other operating partnership unitholders. The merger is expected to close in Q4 2026, subject to SSGT III stockholder approval and other conditions.

• · The merger agreement provides SSGT III with a 42-day 'window shop' period to consider unsolicited alternative acquisition proposals.
• · The transaction is not subject to a financing condition and does not require approval of SST VI's stockholders.
• · The merger was unanimously approved by the boards of directors of both companies and their special committees.
• · SmartStop has an owned or managed portfolio of 460 operating properties in 36 states, Washington, D.C., and Canada, comprising over 275,000 units and more than 35 million rentable square feet.
• · SST VI owned 25 operating self-storage properties as of July 14, 2026, with 13 in the U.S. and 12 in Canada, plus joint venture interests in five operational properties in Canada and one wholly owned development property in Florida.
• · SSGT III owned 12 operating self-storage properties (7 in the U.S., 5 in Canada) plus joint venture interests in one operational and two developmental properties in Canada.

14-07-2026

Ares Management Corporation completed its acquisition of Whitestone REIT for $19.00 per share in an all-cash transaction valued at approximately $1.7 billion. The deal adds 54 retail properties totaling about 4.8 million square feet across fast-growing U.S. markets. As a result, Whitestone will be delisted from public exchanges.

• · Whitestone will no longer be traded or listed on any public securities exchange.
• · Advisors included Citigroup Global Markets Inc. (lead financial advisor and financing provider to Ares), Morgan Stanley (financial advisor and financing provider), Kirkland & Ellis LLP (legal advisor to Ares), Dechert LLP (legal advisor to Citigroup and Morgan Stanley), BofA Securities (financial advisor and fairness opinion provider to Whitestone), Jones Lang LaSalle Securities (financial advisor to Whitestone), and Bass Berry & Sims (legal advisor to Whitestone).
• · As of March 31, 2026, Ares Management Corporation had over $644 billion of assets under management globally.

14-07-2026

On July 14, 2026, two directors (David Johnson and Nino Pionati) voluntarily resigned from the Board of ENvue Medical, Inc. (formerly NanoVibronix, Inc.), and the remaining Board appointed Zvi Joseph and Lior Buchman as replacements. Zeev Rotstein, M.D., was appointed as the new Chairman of the Board. The resignations were not due to any disagreement with the company's operations, policies, or practices.

• · Zvi Joseph was appointed to the Audit Committee and Nominating and Corporate Governance Committee.
• · Lior Buchman was appointed to the Audit Committee and Compensation Committee, and will serve as Chairman of the Compensation Committee.
• · Zeev Rotstein, M.D., was appointed Chair of the Nominating and Corporate Governance Committee.
• · New directors will receive the same fees as other non-executive directors.
• · No transactions requiring disclosure under Item 404(a) of Regulation S-K exist for the new directors.

14-07-2026

First Busey Corporation announced that Chairman, President and CEO Van Dukeman has agreed to a contract extension through July 1, 2029. The filing highlights strong profitability, a quality balance sheet, and a disciplined relationship banking strategy, with assets growing from $4 billion to over $18 billion under Dukeman's leadership. No negative or flat metrics are reported in this filing.

• · Dukeman has been CEO for over 28 years (since 1998 at Main Street Bank and Trust, then at Busey from 2007).
• · Under Dukeman, Busey grew from $4B to over $18B in assets through organic growth and nine strategic acquisitions.
• · Busey has 80 banking centers across 10 states: Illinois (21 in central, 17 in suburban Chicago), Missouri (20 in St. Louis), Texas (4 in Dallas-Fort Worth), Kansas (3 in Kansas City), Florida (3 in southwest Florida), Oklahoma (3), Colorado (3), Arizona (3), Indiana (1 in Indianapolis), Kansas (1 in Wichita), and New Mexico (1 in Clayton).
• · Wealth Management assets under care totaled $15.65B as of March 31, 2026.
• · Dukeman will retain at least 300,000 shares of FBC common stock for two years after his CEO tenure ends.
• · Busey has been named a Best Bank to Work For by American Banker since 2016 and a Best Place to Work in Money Management by Pensions and Investments since 2018.

14-07-2026

Capricor Therapeutics entered into a lease agreement for a new 171,000 sq ft headquarters in San Diego, with monthly base rent of approximately $958,000 and annual escalations of 3.0%. The lease includes an 18-month full rent abatement and a contingency allowing either party to terminate if FDA approval of Deramiocel for Duchenne muscular dystrophy is not received by December 31, 2026.

• · Lease commencement is the earlier of satisfaction of FDA approval contingency or December 31, 2026.
• · Rent commencement date is 12 months after lease commencement.
• · Base rent abatement: 18 months full, then 6 months partial (on 128,068 sq ft).
• · Security deposit of approximately $958,000 may be in cash or letter of credit.
• · Tenant responsible for real property taxes, insurance, maintenance, and operating costs.

14-07-2026

Anika Therapeutics, Inc. entered into a Fifth Amendment to its Credit Agreement with Bank of America, N.A. as Administrative Agent and its lenders, dated July 10, 2026. The amendment reduces the Revolving Facility to $50,000,000 and updates various schedules and exhibits to the credit agreement. This refinancing reflects a material change in the company's credit facilities and leverage profile.

• · The Fifth Amendment modifies the Credit Agreement originally dated October 24, 2017, and previously amended four times.
• · The amendment updates 19 schedules (including Commitments, Material Contracts, Subsidiaries, and Collateral) and 4 exhibits (Compliance Certificate, Loan Notice, Permitted Acquisition Certificate, Notice of Loan Prepayment).
• · Conditions precedent include delivery of officer's certificates, legal opinions, UCC searches, financing statements, and a solvency certificate.
• · Existing indebtedness (other than permitted) must be repaid and related security interests terminated upon effectiveness.
• · The amendment recites no material adverse effect since the date of the audited financial statements.

14-07-2026

Bridgeline Digital, Inc. entered into a Common Stock Sales Agreement with WestPark Capital, Inc. on July 14, 2026, allowing the company to sell shares of its common stock from time to time in an at-the-market offering. The company is not obligated to sell any shares, and no assurance can be given that any sales will occur. The agreement includes a 3.0% commission to WestPark and reimbursement of expenses up to $50,000 plus $3,500 per quarter for ongoing diligence.

• · The Sales Agreement is filed as Exhibit 10.1 and an opinion of counsel as Exhibit 5.1.
• · The offering is made under a prospectus supplement to the company's existing Form S-3 registration statement (File No. 333-285176).
• · Either party may terminate the Sales Agreement at any time upon written notice.
• · The company has agreed to provide WestPark with customary indemnification and contribution rights.

14-07-2026

Willis Lease Finance Corporation (WLFC) announced it has signed a definitive agreement to acquire 12 commercial aircraft and 13 aircraft engines, expanding its lease portfolio and customer base. The acquisition complements WLFC's asset management and aftermarket capabilities, with CEO Austin C. Willis highlighting growth opportunities and the integration of engine-based programs such as ConstantThrust®. The transaction is subject to customary closing conditions.

• · The seller was advised by Vedder as legal counsel and KPMG Ireland as tax and accounting advisors.
• · WLFC's service offerings include Part 145 engine maintenance, aircraft line and base maintenance, aircraft disassembly, parking and storage, airport FBO and ground and cargo handling services.